Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEMBRY
Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEMBRY — FDA update affecting Cosmetics & Personal-Care (MoCRA).
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on September 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetics & Personal-Care (MoCRA) (indie beauty brands, contract manufacturers, private-label makers, importers/distributors) should confirm how it applies to their specific situation before acting. There is a time constraint attached: as soon as possible. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEMBRY
Who it affects
Cosmetics & Personal-Care (MoCRA) (indie beauty brands, contract manufacturers, private-label makers, importers/distributors)
What you must do
Check the effective date and complete any required filing, registration, or update before it takes effect.
Deadline
as soon as possible
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Issues Final Guidance on Facility Registration and Product Listing Under MoCRA - crowell.com
- Agency Information Collection Activities; Proposed Collection; Comment Request; Pregnancy Exposure Registry Enrollment Project: A Survey of Health Care Providers To Advance Pregnancy Safety Data Collection and Improve Health Communications
- Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products
- Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-2027 Southern Hemisphere Influenza Virus Vaccines
- Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates; Guidance for Industry; Availability